close

Enter

Log in using OpenID

See Whos Attending in 2014! - Ophthalmology Innovation Summit

embedDownload
Registered as of 10/16/2014
2020 Management
Eric Weinberg
20/10 Perfect Vision
Frieder Loesel, Managing Director
5AM Ventures
Hannah H. Chang, Associate
Abbott Laboratories
John Capek, Executive Vice President, Medical Devices
Abbott Medical Optics
Leonard Borrmann, Divisional Vice President, R&D
Darren Inouye, Commercial Director Refractive & Global Marketing
Steve Jwanouskos, Associate Director, Regulatory Affairs
Ken Kadziauskas, Associate Director & Marketing, Global Upstream
Terry Koritz, Divisional Vice President, Commercial Refractive
Catherine Mazzacco, Divisional Vice President, Commercial Operations
Jane Rady, Divisional VP, Business Development
MK Raheja, PhD, MBA, Global Head, Cataract R&D
Cameron Rouns, Divisional Vice President, Global Strategic Marketing
Murthy V. Simhambhatla, PhD, President
David Tanzer, MD, Chief Medical Officer, DVP Medical Affairs
Troy Wu, MD, Director, Business Development
AbbVie
Deb van Riet, Director
Anita Riyat, Director, Corporate Strategy
Samir Tari, Clinical Development
Accutome
Joelle Vega, President
Ace Vision Group
Dr. AnnMarie Hipsley, Founder
Acucela
Hien DeYoung, VP, Human Resources
Karin Ludwig, MD, VP, Clinical Development
AcuFocus
Wellentina Greer, Director, Global Strategic Marketing
Matt Larson, Commercial Director, Asia Pacific
Jim Mazzo, Chairman & CEO
Yari Mitchell, Director, Global Medical Education & Professional Relations
Nick Tarantino, Chief Clinical & Regulatory Officer
AECOS
Trudy Larkins, Executive Director
Aerie Pharmaceuticals
Vicente Anido, CEO
Mitchell Delong, Vice President, Chemistry
Casey Kopczynski, Chief Scientific Officer
Brian Levy, Chief Medical Officer
Tom Mitro, President & Chief Operating Officer
Richard Rubino, Chief Financial Officer
Craig Skenes, Vice President, Business Development
Aerpio Therapeutics
Joseph H. Gardner, PhD, President & CEO
AGTC
Jeff Chulay, Vice President & CMO
Dan Menichella, CBO
Susan Washer, President & CEO
Akorn
Adrienne Graves, Former President & CEO
Diane Houtman, Vice President, Profession Relations
Al Consultants
Avner Ingerman, Owner
Alcon
Judith Anderle, Global Product Director, Ocular Allergy
Laurent Attias, Head, Global Commercial Strategy
Sandipan Bagchi, Global Marketing Manager
Sharon Bakalash, MD, PhD, Technical Lead Cataract
David Chacko, Strategic Assistant to the Global Head of Alcon
Arthur Ciociola, VP, Head of Global Regulatory Affairs
Julie Collins, Director, Global Digital Marketing
Fred Ellis, Head, Professional Affairs, US Pharmaceuticals
Robert Fisher, Global Pharma Market Access Director
Heather Floyd, PhD, Technical Lead Pharmaceutical
Jeff George, Global Head
Stephanie Grancharov, Head of Strategy
Paul Hallen, Global Franchise Director-Vitreoretinal
Jim Jogerst, Head, Business Development & Licensing
Oliver Kersting, General Manager
Gregory Kunst, Global Marketing Director, Retina Pharmaceuticals
Franck Leveiller, PhD, VP, Head of Research & Development Vision Care
Sabri Markabi, MD, CMO & Head R&D
Anmol Mullins, Director, Global Market Access
Jim Murphy, VP & GM, US Vision Care
David Nieto, Chief Financial Officer
Aaron Osborne, Head, GMA Pharma Franchise
Scott Pennington, Head, R&D Alliances
Dr. Cadmus Rich, Therapeutic Unit Head, IOLs
Peter Richardson, CMO, Head Global Clinical & Regulatory Affairs
Lukas Scheibler, PhD, VP, Ideation Center
Gregg Stanhope, Director, Professional Affairs, US Pharmaceuticals
Catherine Truitt, PhD, Technical Lead, VGR
Robert Warner, Area President, United States & Canada
Gergely Zimanyi, Director of Intellectual Property
Alexion Pharmaceuticals
Bill Lundberg, Vice President
Alimera Sciences
Rick Eiswirth, Chief Operating Officer & Chief Financial Officer
C. Daniel Myers, President & Chief Executive Officer
Alkeus Pharmaceuticals
Leonide Saad, President & CEO
Allegro Ophthalmics
Hampar Karageozian, Co-Founder & CEO
Vicken Karageozian, MD, Co-Founder & Chief Technology Officer
Maria Leone, Business Development Consultant
Allergan
Yehia Hashad, VP, Global TA Head, Retina
Gavin Herbert, Founder
Patrick Johnson, Sr. Director, Business Development
David Pyott, Chairman of the Board and CEO
Brian Strem, Director, Business Development
Ramin Valian, VP, Global Strategic Marketing, Eye Care
Scott Whitcup, MD, Executive Vice President, Head of R&D & Chief Scientific Officer
Allysta Pharmaceuticals
Benson Fong, CBO
Henry Hsu, CEO
Alphaeon
Robert Grant, CEO
Jenna Mons, VP of Marketing
Tony Sine, EVP Business Development
Shareef Mahdavi, Chief Marketing Officer
David Mordaunt, President
Altacor
Dr. Francesca Crawford, CEO
Amakem
Jack Elands, CEO
Steve Pakola, Chief Medical Officer
Kieran Rooney, VP, Business Development
American Academy of Ophthalmology
Jane Aguirre, Vice President, Global Alliances
David W. Parke, MD, CEO
Richard Zorab, Vice President, Clinical Education
AmorChem
John Clement, General Partner
AnalyzeRx
Sanjay Nayak, MD, PhD, Founder
Apellis Pharmaceuticals
Cedric Francois, CEO & President
Federico Grossi, VP of Clinical Development
David Watson, Executive VP of Development
Apex Eye
Robert Benza, MD, PI
Ed Meier, MD, Director of Clinical Research
Wendy Shoger, Director, Clinical Research Development
Appletree CI Group AG
Todd Galles
Georg Mathis, Physician
AppMedicine
Robby Huang, CEO
Aquesys
Ron Bache, CEO
ASCRS
Don Bell, COO
Eric Donnenfeld, MD, President
David Karcher, Executive Director
ASCRS Media
Jeff Brownstein, Director of Sales
Donald Long, Director of Media
Cathy Stern, Production Manager
Paul Zelin, Sales Representative
ASSORT
Noel Alpins, CEO
Tom Barker, Director of Business Development & Strategic Alliance
Doug Mastel, Product Specialist
Avalanche Biotechnologies
Linda Bain, Chief Financial Officer
Samuel Barone, Chief Medical Officer
Thomas W. Chalberg, PhD, Founder & CEO
Hans Hull, SVO Business Operations
Roman Rubio, Head of Translational Medicine
Avedro
Steve Blinn, Chief Commercial Officer
David Muller, President & CEO
Avelino Lab USA
Scott Korney, COO
Gene Lee, Chairman & CEO
Weston Nichols, Director, Sales & Marketing
Avella
Leslie Yendro, VP, Business Development
BAM Ophthalmology Consultants
Beth Marsh, Principal
Barclays
Priya Karani, Director
Jonathan Piazza, Director
Bascom Palmer Eye Institute
William Culbertson, Professor of Ophthalmology
Philip Rosenfeld, MD, Professor of Ophthalmology
Bausch + Lomb
Andrew Chang, Vice President, Sales & Marketing
Chuck Hess, Sr. Director of Marketing
Raymond Larwood, Vice President Pharmaceutical Sales
Sanjay Malieckal, Director, Marketing
Quintus Ngumah, Director Clinical Development & Medical Strategy
Calvin W. Roberts, MD, Executive Vice President & Chief Medical Officer
Tracy Valorie, Vice President, Pharma Marketing
Jon Williams, Director, Medical Affairs
Bay Area Retina
Roger Goldberg, Physician
Bayer Healthcare
Robert Lieberman, Associate Director, Global Market Research
Bayer HealthCare Pharmaceuticals
Tom Cordaro, Director, Strategy & Portfolio Management
Ken Shaw, PhD, Sr. Director, BD&L & SM
Baylor College of Medicine
Jack Holladay, MD, Clinical Professor of Ophthalmology
Beaver Visitec International
Peter Hemingway, V.P. Strategy & Business Development
BioComm Network
Tad Heitmann, MBA, President
Biolight
Suzana Nahum Zilberberg, CEO
BioQuest
Roger Anderson, Partner
Karen Bertrand, SVP, Biopharmaceutical Practice Leader
Biosyntrx
Ellen Troyer, CEO & Chief Research Officer
Bio-Tissue
Greg Sorenson, Business Development Rep
Brar-Parekh Eye Associates
Jai Parekh, MD, Managing Partner
Bryn Mawr Communications
David Cox, President & Group Publisher
Steve Daily, News Director
Alan Guralnick, Group Publisher
David Levine, Vice President, Digital Division
Bucci Laser Vision Institute
Frank A. Bucci, President & Founder
Bullseye Dropper
Robert Behan, Director
C.C.G. Partners
Rick Coulon, Managing Partner
California Pacific Medical Center
Rona Silkiss, Chief, Div. of Ophthalmic Plastic, Reconstructive & Orbital Surgery
Calpain Therapeutics
Tim Lovell, CEO
Cantor Fitzgerald
Caroline Corner, Research Analyst
Carle
Michael Tsipursky, Physician
Carl Zeiss Meditec
Scott Meyer, Director, Strategic Business Development
Vincent Patella, VP Professional Affairs
Angelo Rago, SVP, Innovation & Operations
Catalyst Biosciences
Nassim Usman, CEO
Cativer Bio Insights
Stephen Judd, President
Center for Excellence in Eye Care
William Trattler, Director of Cornea
Charles Retina Institute
Steve Charles, Founder & CEO
CheckedUp
Richard Awdeh, Founder & CEO
Mark Awdeh, CFO
CHU Gabriel Montpied
Dr. Hayette Rebika, Ophthalmologist
Cincinnati Eye Institute
Edward J. Holland, MD, Director, Cornea Services
Citadel
Erik Ostrowski, Analyst
Clarion Healthcare
Carol Kearney, Managing Director
Clarity Medical Systems
Barry J. Linder, MD, MS, CMO
Rick Mangum, CFO
Mark Mellin, CEO
Clarus Ventures
Emmett Cunningham, Jr., MD, PhD, MPH, Partner
Nick Galakatos, Managing Director
Michele Park, Principal
Kurt Wheeler, Managing Director
ClarVista Medical
Glenn Sussman, VP, R&D
Clearview Eye & Laser Medical Center
Sandy Feldman, Medical Direcor
ClinOps International
Yordak Salermo, Clinical Consultant
ClinReg Consulting Services
Judy Gordon, President
Lee Kramm, MD, Senior Regulatory Consultant
Roger Meyer, MD, Consultant
Cockrell Interests
Bobby Hatcher, CEO
Cole Eye Institue
Neema G. Mayhugh, Director of Commercial Affairs
Columbia University Medical Center
Stephen Trokel, Vice Chair, Department of Ophthalmology
Cornea/Retinal Diseases Image Analysis Reading Centers
Beth Ann Benetz, Director
Cressey & Company
Steve Dildine, Vice President
Cydan
Aileen Healy, PhD, Vice President, Preclinical Developent
D.O.R.C. International
Pieter Karels, Strategic Product Development Director
Willem Rosenquist, Strategic Product Management Director
Dean McGee Eye Institute
Gregory Skuta, President & CEO
Department of Ophthalmology & Vision Sciences, UC Davis
Christopher Murphy, Professor of Comparative Ophthalmology
Destum Partners
Matt Vanderberg, Managing Director, Partner
DiagnosTear
Nimrod Bin-Nun, Business Development
DigiSight Technologies
Doug Foster, CEO
Draper Laboratory
Brian Daniels, Program Manager
Durrie Vision
Daniel Durrie, MD, Founder & President
EagleVision
Murray Beard, President
Eleven Biotherapeutics
Abbie Celniker, CEO
Michael Goldstein, MD, MBA, Vice President of Clinical Research
Greg Perry, CFO
Gary Sternberg, Executive Vice President of Corporate & Business Development
Karen Tubridy, Chief Development Officer
Encompass Pharmaceutical Services
Thomas Rowe, President
Encore Vision
Bill Burns, President & CEO
Envisia Therapeutics
Neal Fowler, CEO
Tomas Navratil, Vice President, Development
Ash Nijhawan, Vice President, Business Development
Ben Yerxa, CSO
Escalon Medical Corp.
Matt Carnevale, Chief Technology Officer
Richard J. DePiano, Jr., CEO
Barry Durante, President
Enrique Pfeiffer, Chief Medical Officer
Mark Wallace, COO
Ethis Communications
David Kellner, Exectuvie VP
Lavon Kellner, Principal Director of Sales
Luca Sergio, CEO
Eton Park Capital
Matt Reischl, Analyst
EuroTimes
Howard Larkin, Contributing Editor
ExSight Capital
James Murray, Partner
Eye Associates of Washington D.C.
Paul Gavaris, MD, President
Eye Consultants of Texas
Phillips Labor, Physician
Eye Surgeons Associates
Lisa Arbisser, Physician
Eye Therapies
Tony Moses, CEO
EyeGate Pharma
Stephen From, CEO
Michael Manzo, VP of Engineering
EyeKor
Ron Danis, Managing Partner, CSO
EyeNet Magazine
Patty Ames, Executive Editor
Peggy Denny, Senior Editor
Chris McDonagh, Senior Editor
Edna Shaw, Contributing Writer & Editor
EyeQ Research
Michael Lachman, Founder
EyeSonix
Don Schwartz, President
EyeWorld
Erin Boyle, Editor
Julio Guerrero, Video Editor
Lauren Lipuma, Staff Writer
Ellen Stodola, Staff Writer
FDA
Kesia Alexander, Deputy Director
Wiley A. Chambers, MD, Supervisory Medical Officer, Division of Transplant & Ophthalmology Products
Malvina B. Eydelman, MD, Director, Division of Ophthalmic Device Evaluation
Eva Rorer, Medical Officer
Michelle Tarver, MD, Medical Officer
Federal University of Sao Paulo
Rubens Belfort, Head Professor
Cristina Muccioli, MD, Professor of Ophthalmology
FishmanVision
Harvey Fishman, Medical Director
Foresite Capital
Stella Sarraf, Advisor
ForSight Labs
Eugene de Juan, MD, Founder & Vice Chairman
Angela Macfarlane, President & CEO
ForSight Vision4
Signe Erickson, VP, Development & Clinical
ForSight VISION5
Charles Semba MD, Chief Medical Officer
John Maroney, President & CEO
Anne Rubin, Vice President, Marketing
Foundation Fighting Blindness
Tom Capetan, Business Development Consultant
Patricia Zilliox, Chief Drug Development Officer
GE Capital, Healthcare Financial Services
David Anderson, Managing Director
Genentech
Bonaventure Agata, Disease Area Director – Ophthalmology
Eugene An, GPM
Warner Biddle, Vice President Lucentis Ophthalmology Sales & Marketing
Ann Clark, Senior Medical Science Liaison
Warren L. Creed, Clinical Specialist
Atul Dandekar, Lifecycle Leader
Jason Ehrlich, Group Medical Director
Guillermo Elias, Senior Product Manager
Carl Erickson, GPM
Daniela Ferrara, Associate Medical Director
Caroline Hartford, Senior Product Manager
Daniel Kindelberger, Product Management
Thomas Kochy, Director, Pipeline Strategy
Phillip Lai, Senior Medical Director
Georgia Li, Medical Director
Chad McCrea, SPM
Ajay Narasimha, Senior manager
Lisa Tuomi, Senior Clinical Scientist
Elisabeth Warren, Associate Director, Pipeline Strategy
Thomas Zioncheck, Senior Director, Business Development
Glaucoma Research Foundation
Tom Brunner, President & CEO
GlaxoSmithKline
Claudine Bruck, VP & Head Ophthalmology R&D
Rabia Ozden, MD, Head, Clinical Ophthalmology R&D
Gobiquity
Michael Brownell, CEO
Google X
Brian P. Otis, PhD, Founder, Smart Contact Lens Project
GrayBug
Michael O'Rourke, CEO
Gray Communications
Michele Gray, Principal
Great Point Partners
Aaron Hakim, Analyst
Gurnet Point Capital
Todd Holmes, Director
Anne Rogove, Analyst
Gustavson Development
Michael Gustavson, President
GZ Paul Management Services
Helmut A. Krueger, Director
Harvard Medical School
Jonathan H. Talamo, MD, Associate Professor of Ophthalmology
Healios
Al Reaves, Director & Chief Development Officer
HealthCare Royalty Partners
Matt Reber, Managing Director
HealthCor Partners
Ed Ross, Analyst
Healthios Capital Markets
Greg Shearer, Managing Director
Hospital das Clinicas
Mauro Goldbaum, Ophthalmologist
Hoya Corporation
Akiteru Furukawa, General Manager
Takashi Iizuka, Manager, Business Development
i-Optics
Jeroen Cammeraat, CEO
Wayne Caulder, Cassini VP North America
David Friess, Clinical Consultant
Icare Finland
Ari Kukkonen, R&D Director
iCo Therapeutics
Dr. Peter Hnik, Chief Medical Officer
Susan Koppy, Corporate Business Development Executive
Andrew Rae, CEO
Icon Bioscience
Hector Casab, VP Finance
David Tierney, CEO
Iconic Therapeutics
Bill Greene, CEO
Tanya Shnaydman, Director, Corporate Development & Operations
IDDI
Linda Danielson, COO
Stan Wysocki, Senior Director, Business Development & Sales Operations
Illinois Eye & Ear Infirmary
Ahmad A. Aref, MD, Assistant Professor of Ophthalmology
Yannek Leiderman, Vitreoretinal Surgeon
Illinois Institute of Technology
Jennifer Kang-Mieler, Associate Professor of Biomedical Engineering
Imex Clinic SL
Jose Maria Gimeno Reiz, President & CEO
Implandata Ophthalmic Products GmbH
Max G. Ostermeier, CEO & President
Imprimis Pharmaceuticals
Bindu Manne, Regional Business Director
Indiana University
Alon Harris, MS, PhD, FARVO, Director, Clinical Research
Infinite Vision Optics
Carsten Laue, CEO
Infinov
Benoit Collet, President
Ingeneus
Richard Walmsley, CEO
InnFocus
Russ Trenary, President & CEO
Guy Van de Weyer, Director Operations Europe, Middle East, Africa
Integrity Digital Solutions
Chris Moore, CEO
InterWest Partners
Charline Gauthier, Executive-in-Residence
Gilbert H. Kliman, MD, Managing Director
Reza Zadno, Venture Partner
Intralase
Ronald Kurtz, CEO
IOPtima
Ronen Castro, CEO
Iris Advanced Eye Centre
Raman Bedi, MD, Physician
Iris Pharma
Pierre-Paul Elena, CEO
Yann Quentric, Head of Business Development & Marketing
ISOPT
Dr. Sara Krupsky, Chairperson
iSTAR Medical
Pierre Geens
Michel Vanbrabant
Ivantis
Dave Van Meter, CEO
J.P. Morgan
Michael Gaito, Managing Director & Head of West Coast Life Sciences
Jeffrey Hoffman, Managing Director, Head West Coast Healthcare Investment Banking
Janssen Pharmaceuticals
Susan Orr, Global Medical Affairs Leader, Ophthalmology
Janssen Research & Development
Rob Willenbucher, Head Cell Therapy & Janssen Incubators
Japan Focus
Makoto Wakayama, Assistant Manager
Jefferies
Biren Amin, Managing Director
JFC Sales Plan
Masataka Fujikawa, Chief
Tsugitomo Takimoto, Chairman
John Guckes & Associates
John Guckes, President
Johnson & Johnson
Ellie Chabi, MD, Physician
Hassan Chaouk, X
Louis Dias, Director
Christine Knoblauch, Vice President, WW Business Development
Ashley McEvoy, Company Group Chairman
Brian Schwam, Chief Medical Officer
Art Shedden, MD, MBA, Senior Director, Global Medical Affairs
Peter Shen, VP WW R&D
JP Morgan
Jeffrey Hoffman, Managing Dir. & Head West Coast Healthcare Investment Banking
JRM Holdings
Jose Roberto Alegre, CEO
Jump Capital
Garrett Vygantas, MD, Partner
JunoPacific
Kern Bhugra, President
Kaiser Associates
Dan O’Neill, Senior Vice President
Bob Serrano, Vice President
Kala Pharmaceuticals
Kim Brazzell, Chief Medical Officer
Charlie McDermott, Chief Business Officer
Kato Pharmaceuticals
Terry McGovern, CEO
Kepler
Schalon Newton, Principal
Kraff Eye Institute
Colman R. Kraff, MD, Director of Refractive Services
Laboratories Thea
Francou Colin, Corporate Business Development Manager
Pascale Pouliquen, Corporate Medical Director
Laboratories SALVAT
Hugo Peris, Board Member
LacriPen
Jay M. Eastman, Professor
Chris D. Geddes, Biochemical Engineer
LayerBio
Ken Mandell, CEO
Leerink Partners
Tony Gibney, Managing Director
Joseph Schwartz, Managing Director
Leica Microsystems AG
Heinrich Dreyer, Vice President, Medical Division
LensGen
Michael Colaco, Board Member
Shivbir Grewal, Board Member
Michael Landreville, Chief Operating Office
Ram Rao, CEO
Lensar
Nick Curtis, CEO
Pete Mariani, CFO
Lenticular Research Group
George McArdle, OD, Optometrist
Leonidas A Johnson, O.D., APC
Leonidas Johnson, Optometrist
Lifecore Biomedical
Kipling Thacker, PhD, Chief Scientific Officer & VP
Linden Capital Partners
Tony Davis, Managing Partner
Eric Larson, Managing Partner
Link Consulting
Marsha Link, PhD, Principal
London Eye Hospital Pharma
Rob Hill, CEO
Longitude Capital
Juliet Bakker, Managing Director
Andrew ElBardissi, Vice President
Lumenis
Ezer Bar-Aviv, Business Development Surgical Business Unit
Assaf Gelstein, Director, Global Products
Liat Hadad, Director, Product Marketing
Flavio Longato
Itay Mayer, Director, Product Marketing
Adi Rizansky Nir, Global Product Marketing Manager, Vision Business Unit
Lumoptik Eye
Thomas Janicki, President
Lutronic
Haelyung Hwang, President
Jongmin Kim, CTO
M&S Technologies
Joseph Marino, President & CEO
Managed Care First Report & P&T Magazine
Peter Sonnenreich, Senior Editor
Mark Packer MD Consulting
Mark Packer, President
Market Scope
Bill Freeman
Massachusetts Eye & Ear
Bonnie M. Brodowski, MBA, Program & Business Development Manager
Reza Dana, MD, MPH, MSc, Claes H. Dohlman Professor of Ophthalmology
Ojas Mehta, Director, IP & Commercial Ventures
Jonathan Talamo, Site Director
Mati Therapeutics
Bob Butchofsky, CEO
Chris Muller, CCO
Mayo Clinic
Arthur Sit, Associate Professor
MC2 Biotek
Frederic Gomez, Advisor, Business Development
Jesper J. Lange, President
Morten Prostegaard, VP Operations
McMaster University
Zuhal Butuner, Associate Professor
medeuronet
Kristine Morrill, Managing Director
Medical Device Daily
Larry Haimovitch, Reporter
Medicem
Eugen Chicevic, Managing Director
Giacomo Nizi
Vladimir Stoy, President
Mediphacos Ophthalmic Professionals
Gustavo Couri, Commercial Director
Marcelo Soares, President
Mercy Eye Clinic
Jack Bussa, MD, Physician
MicroOptx Medical
Chris Pulling, CEO
Mid Atlantic Bio Angels
Eric D. Kanter, MD, Partner
Mid Atlantic Retina-Wills Eye Institute
Carl Regillo, MD, Professor of Ophthalmology
Mimetogen Pharmaceuticals
Garth Cumberlidge, President & CEO
Francois Mongrain, CFO
Minnesota Eye Consultants
Richard Lindstrom, MD, Founder & Attending Surgeon
Mobius Therapeutics
Jim Brocato, Director, National Accounts
Ed Timm, President & CEO
Monash Vision Group
Jeanette Pritchard, General Manager
Moorfields Pharmaceuticals
Rob Wallace, Business Development Director
MT Coroneo Pty Ltd
Minas Coroneo, Professor
Mynosys Cellular Devices
John N. Hendrick, President & CEO
Mystic Pharmaceuticals
Timothy Sullivan, President & CEO
Nanovision Group
Anton Archipov, President & CEO
National Eye Institute, NIH
Matthew J. McMahon, PhD, Director, Office of Translation Research
Navigant
Derakhshan Behrad, Physician
Jeff Evanson, Healthcare Consultant
Todd Waldman, Director
NDC
Edwin Keates, Consultant
Neurotech
Quinton Oswald, CEO
Rhett Schiffman, VP & CMO
Rich Small, CFO
NeuroVision
Steven Verdooner, CEO
New World Medical
Suhail Abdullah, Director, Research & Development
Bilal Khan, Vice President & Chief Operating Officer
NextGen Healthcare
Tera Roy, Specialty Director, Ophthalmology
Nicox
Mike Bergamini, EVP & Chief Scientific Officer
Gavin Spencer, EVP, Corporate Development
NIDEK
Tokio Ueno, Senior Manager
Nightstarx
Aniz Girach, CMO
nJoy Vision
Dawn Holsted, President & CEO
North Shore LIJ Health System
Ira Udell, Physician, Chairman
NotalVision
Yair Alster, CMO
Barak Azmon, CEO
Scott Jones, President
Novaliq GmbH
Gerald Cagle, MD, Physician
Bernhard Guenther, CEO
Frank Loescher, Director, Business Development
Tony Pettigrew, Director, New Products
Dieter Scherer, CSO
Hartmut Voss, Executive Advisor
Novartis Pharma
Ronny Hashmonay
Dirk Sauer, Global Head, Development Franchise Ophthalmics
Mark Wuttke, Global Brand Manager, New Products, Medical Retina
Edward Wright, BD&L Manager
Novozymes Biopharma
Michael Foldager, Global Marketing Manager
NSBRI
Dorit Donoviel, PhD, Deputy Chief Scientist and Industry Forum Lead
Nudrop
David Cohen, Commercial Direcor
Ocugen
Charlie Kang, CEO
Ocular Instruments
Scott Corning, VP, Sales & Marketing
Phil Erickson, President
Raymond Graham, Director of Engineering & Product Development
Amar Sawhney, PhD, President & CEO
Brad Smith, CFO
Ocularis Pharma
Alan R. Meyer, CEO
Oculeve
Michael Ackermann, President & CEO
Daniel Hamilton, Vice President, Clinical Affairs
OCULUS Surgical
Ron Gilliland, President and CEO
Bob Zatarain, V.P. Business Development
OD-OS
Ulrich Kinzel, Consultant
Dr. Winfried Teiwes, CEO
Oftalmedica
Benedetto Sgroi, CEO
OHR Pharmaceutical
Irach Taraporewala, CEO & President
OneFocus Vision
Steve Waite
ONL Therapeutics
John Freshley, CEO
David Zacks MD, PhD, Co-Founder and CSO
Oligasis
Victor Perlroth, Founder & CEO
Opthalmiatreion Athens Eye Hospital
Iordanis Chatziangeldis, Ophthalmologist
Ophthalmology Times
Mark Dlugoss, Editor-in-Chief
Ophthotech
Mike Atieh
Richard Beckman, Senior Vice President
Hans Christinger, VP, Business Development & Alliance Management
Kathy Galante, Vice President, Investor Relations
David R. Guyer, MD, CEO
Jeffrey Nau, VP, Clinical & Medical Affairs
Samir Patel, President
Michael Rafa, VP & Chief Patent Counsel
Keith Westby, Sr. Vice President, Program Management & Business Operations
Barbara Wood, SVP, General Counsel & Corporate Secretary
Oppenheimer & Co
Yigal Nochomovitz, Analyst, Equity Research
OptiMedica
Mark Forchette, Former CEO
Ora
Stuart Abelson, President & CEO
Ryan Bouchard, Director, Medical Devices
Matthew Chapin, Sr. VP, Corporate Development
Phil Gioia, Corporate Development
Mashfiq Haque, Director, Business Development
Eliot Lazar, Physician
Hiro Matsuda, General Manager
Joshua Moriarty, Director, Medical Communications
George Ousler, Vice President, Dry Eye
MaryJane Rafii, Director, Business Development
Van Sandwick, Corporate Development Associate
Aron Shapiro, Vice President
Oraya Therapeutics
Jim Taylor, President & CEO
Pacific Eye & Laser Institute
Rochelle Rongavilla, Research Supervisor
Jimmy Tan, Managing Director
Harvey Uy, Medical Director
Palo Alto Investors
John Doux, Physician
Pamel Vision & Laser Group
Elizabeth Jett, Clinical Research Coordinator
Gregory Pamel, Owner
Panoptes
Franz Obermayr, CEO
PanOptica
David P. Bingaman PhD, DVM, ACVO, Sr. Director & Head, Retina Development
Paul Chaney, President & CEO
Marty Wax, MD, Chief Medical Officer & EVP, R&D
Paragon BioTeck
Patrick Witham, CEO
Parexel International
Patricia Cominsky, Senior Director, Business Development
Parion Sciences
Jose Boyer, VP Research & Ophthalmology Development
Pascale Communications
Georgette Pascale, President & CEO
Pasteur Ophthalmic Clinic
Jaime Zacharias, Physician
Patterson Thuente IP
Paul Onderick, Intellectual Property Attorney & Eye Doctor
PentaVision
Rich Kirkner, Executive Editor
Andrew Mathis, Managing Editor of Retinal Physician
Perceptive Life Sciences Fund
Hossein Ekrami, Senior Analyst
Pharmacos
Jim Currie, Principal
PharmaQuest Associates
Lisa Grillone, President
Phillips Medisize
Vince Hull, Director, Product Development
Joe Slade, Program Manager
Piper Jaffray & Co.
J.P. Peltier, Managing Director and Global Group Head of Healthcare Investment Banking
PowerVision
Barry Cheskin, President, CEO & Co-Founder
Matt Frinzi, Chief Business Officer & Founder
PRECEYES
Gerrit Naus, CEO
Atul Sinha
Presbia
Vlad Feingold, Executive VP & CTO
Zohar Loshitzer, President
Promedica
Shannon Stoddard, President
pSivida
Paul Ashton, CEO
Quantel Medical
Peter Falzon, Business Development
Rainbow Medical
Roy Katz, VP Business Development
Refocus Group
Mark Cox, Executive Vice President
Mike Judy, CEO
Stephon C. Payseur, Director Strategic Communications
Regeneron
Keith Baker, Associate Director of Medical Affairs, Ophthalmology
Abby Cahn, Sr. Manager Strategic Accounts Planning
Nouhad Husseini, Senior Director
Husain Kazmi, Director Clinical Sciences, Ophthalmology
Neil Levine, Sr. Director of Marketing
John Magliocchetti, Sr. Director Ophthalmology, New Products Marketing
Carl Romano, Executive Director, Ophthalmology
Namrata Saroj, Sr. Medical Director Medical Affairs, Ophthalmology
Reichert Technologies
Chris Thatcher, Division Vice President & Business Unit Manager
Replenish
Ted Danse, CEO
Retina Associates
Ben Z. Cohen, Physician
Retina Consultants
Charles Vygantas, MD, Physician
Retina Consultants of Delmarva
Jeffrey Benner
Retina Health Center
Alexander Eaton, MD, Physician
Retina-Vitreous Associates
David Boyer, MD
Steven Cohen, MD, Partner
Firas M. Rahhal, MD, Partner
RetinaNet
Mark Nelson, MD, MBA, CEO
RetroSense Therapeutics
Sean Ainsworth, CEO
ReVision Optics
Luis Vargas, MD, VP, Medical Affairs & Medical Director
Roche Innovation Center New York
Patrick Schleck, Director, Global Business Development
Rocky Mountain Ophthalmology
Kevin Cuevas, Cornea Specialist
Rohto pharmaceutical
Takahiro Kurose, Business development
Ron Neumann
Ron Neumann, Physician
Rowen Laser Vision Center
Sheri Rowen, Medical Director
Rutgers-New Jersey Medical School
Marco Zarbin, MD, Professor & Chair, Institute of Ophthalmology & Visual Science
RxGen
Christopher Stanley, VP & CBO
RXi Pharmaceuticals Corporation
Geert Cauwenbergh, President & CEO
SalutarisMD
Maryline Boulay, Corporate Development & EU Affairs
Laurence Marsteller, MD, CEO
Sandbox Strategic
Amy Jacobs, Vice President
Dawn Thompson, President & Co-Founder
Santen
Yusuf Ali, VP, R & D
Masato Asai, Head
Robert Bauer, Manager
Harumi Kawabata, Licensing Coordinator
Jerome Martinez, President
Sri Mudumba, Sr. Director, Pharmaceutical Dev.
Takashi Noaki, Scientific Affairs & Global Business Development
Ram Palanki, Vice President
Ken Shimokawa, Senior Manager
Tatsuyuki Yamane, Senior Manager, Global BD
Scheie Eye Institute/University of Pennsylvania
Alexander Brucker, MD, Professor of Ophthalmology
Second Sight Medical Products
Robert Greenberg, MD, PhD, President & CEO
See Clearly Vision Group
Dr. Rajesh Rajpal, Physician
Sensimed AG
David Bailey, CEO
Sentinel Diagnostic Imaging
David Meadows, CEO
Sharklet Technologies
Mark Spiecker, CEO
Shifamed
Mariam Maghribi, Chief Business Officer
Shire
Robert Dempsey, Vice President & Business Unit Head
Kathryn Gregory, Sr. Director Business Development
Reza Haque, MD, Vice President, Ophthalmology
Scott Hunter, US Marketing Lead – Ophthalmology
Jeanette Ilett, Business Unit Partnership
Keyur Patel, MD, Medical Science Liaison Lead
Gregory Robinson, Senior Director, Scientific Licensing
Monica Roy, Director, Clinical Development, Ophthalmology
SightLife
Monty Montoya, President & CEO
SightLine Partners
Buzz Benson, Managing Director
Joe Biller, Managing Director
Sightpath Medical
Joel Gaslin, VP of Sales & Marketing
Signet Healthcare Partners
Joyce Erony, Managing Director
Silicon Valley Bank
Hans Hinrichs, Managing Director
Brett Maver, Director
Singapore Eye Research Institute
Dr. Danny Belkin, Business Development Director
Xiaoqin Fang, Technology Development Manager
Slack
Samantha Costa, Online Managing Editor
David Mullin, Editor-in-Chief
Joan-Marie Stiglich, Chief Content Officer
South Florida Vision Associates
Jennifer Loh, Physician
Square 1 Partners
Lauren Kanner, Co-Founder & Strategist
Stanford University
Mark Blumenkranz, MD, Professor & Chairman, Department of Ophthalmology
Suzann Pershing, MD, Chief, Ophthalmology & VA Palo Alto Health Care System
Kuldev Singh, MD, Professor
Stein Eye Institute, UCLA
Steven Schwartz, Retina Division Chief
Stem Cells
Joel Naor, VP, Clinical Development, Ophthalmology
Strategic Intelligence
Babak Nemati, President
Strategic Pharma Solutions
Courtney Kaprelian, COO
Stroma Medical Corporation
Douglas Daniels, CEO
Summit Eye Associates
William Gates, Physician
Surgilum/Surgical Eye Care
Alan Brown, MD, President
SurgiVision Consultants
Guy M. Kezirian, MD, President
SV Life Sciences Advisers
Jim Watchtman, Venture Partner
SVB Capital
Jonathan Norris, Managing Director
SVLSA
Steven Straus, None
Taejoon Pharm
Joon Youb, PhD
TearScience
Nicole Wicker, CFO
TearScience
Tim Willis, President & CEO
Technolas
Kristian Hohla, CEO
Teva Pharmaceuticals
Jeanne Andronowitz, Global Marketing Director
Christine Foster, VP, Search & Evaluation
Diane Harvey, Senior Director, Search & Evaluation
Texas Retina Associates
Karl Csaky, MD, PhD, Partner
The Center for Eye Care & Optical
James F. Collins, MD, Founder & Medical Director
The Foundry
Hanson Gifford, Partner
The Fundingsland Group
Bradley Fundingsland, President
Erin Schalhorn, Vice President
The Glaucoma Foundation
Scott Christensen, President & CEO
The Magnum Group
Randy McDonald, Managing Director & President
The New York Eye & Ear Infirmary
Robert Ritch, MD, Surgeon Director & Chief, Glaucoma Services
The Retina Clinic
Kartik Patel, Physician
Theravance Biopharma
Jeff Finer, VP Research, Molecular & Cellular Biology
Thomas Resource Group
Terry Thoma
ThromboGenics
Laurens Bouckaert, Global Marketing Director
Jean Feyen, PhD, Head Preclinical Research
Pascal Merchiers, Head Project Development
David Pearson, Global Head, Corporate Development
Topcon
Michael Sinai, Senior Manager, Product Planning
Transcend Medical
Ginger Clasby, VP, Clinical & Regulatory Affairs
Michael Schaller, R&D Manger
Brian Walsh, CEO
Translatum Medicus inc (TMi)
Shelley Boyd, President & CSO
Trial Runners
Patrick Healy, CEO
TrueVision Systems
Mark Maire, Vice President of Sales
Burton Tripathi, CTO & EVP of Product Development & Operations
Tufts Medical Center
Daniela Ferrara, MD, PhD, Assistant Professor of Ophthalmology
UCLA School of Medicine
David Sarraf, MD, Clinical Professor, Ophthalmology
UCSF
Daniel Schwartz, MD
David Sretavan, Professor
United Scientific Associates
Dr. Hakam Ghabra
University of California San Diego
Robert Weinreb, MD, Chairman & Distinguished Professor
University of California SF
Stephen McLeod, MD, Professor & Chairman
University of California, Irvine
Roger Steinert, MD, Professor & Chair
University of Florida
William Hauswirth, PhD, Rybaczki-Bullard Professor of Ophthalmology
Nick Muzyczka, Dept of Molecular Genetics & Microbiology
University of Illinois at Chicago
Dimitri Azar, Dean of College of Medicine
William Mieler, MD, Professor & Vice-Chairman
Suseelan Pookote, Senior Technology Manager
University of Rochester
Prof. Wayne H. Knox, Professor Optics & Visual Science
Scott MacRae, MD, Director of Refractive Surgery, Professor of Visual Science
University of Southern California
Mark Humayun, MD, PhD, Professor
University of Sydney
Michael Lawless, Clinical Associate Professor
University of Toronto
Joseph Ma, Assistant Professor
Unilife
Gautam Shetty, Director & General Manager
USC
Rohit Varma, Professor & Chair
UW School of Medicine & Public Health
Paul Kaufman, MD, Professor & Chair
Valeant - Bausch & Lomb Division
Baldo Scassellati Sforzolini, VP, Development Eye Care
Johnson Varughese, Executive Director, Clinical Development
Valley Retina Institute
Dr. Victor Gonzalez, Physician & Founder
Vance Thompson Vision
Vance Thompson, MD, Director of Refractive Surgery
VCU, Richmond/INOVA Fairfax Hospital
Michael Ross, MD, Professor
Venture Investors
Jim Adox, Managing Director
Versant Ventures
Andy Corley, Venture Partner
William J. Link, PhD, Managing Director
Charles Warden, Managing Director
Vestrum Health
Nadeem Ahmad, Director of Operations
Nicholas Anderson, Co-Founder
Tom Brogan, CEO
John Pollack, Co-Founder
David Williams, Co-Founder
Visometrics
Jan Bonel, CEO
VisionCare Ophthalmic Technologies
Allen Hill, CEO
Vision Medicines
Brinda Balakrishnan, MD, PhD, Senior Director Product Development & Strategy
Jonae Barnes, SVP, Investor Relations & Corporate Communications
Robert Kim, Vice President Research & Development
Chris Varma, CEO
VisuMedics
George Marcellino, Vice President
Vital Art & Science
George Mavro, CMO
Vitreous Retina Macula Consultants of New York
Bailey Freund, MD
Vittamed Corporation
Remis Bistras, CEO
VRMNJ
Vatsal Doshi, Physician
WaveTec Vision Systems
Craig Bender, Chief Operating Officer
Michael Breen, VP, Clinical
Scott Cooper, CFO
Thomas Frinzi, CEO
Whipps Cross University Hospital
Marwan Ghabra
Williams Eye Surgery
Johnny Williams, MD, Physician
Wills Eye Institute
Julia Haller, MD, Ophthalmologist-in-Chief
Wilmer Eye Institute
Howard Ying, Associate Professor of Ophthalmology
WilmerHale
Brian Johnson, Partner
Windham Ventures
Cynthia Yee, Principal
Woodhams Eye Clinic
George Waring, III, Physician
Wordsmith Consulting
Jan Beiting
Xcovery Vision
Teri Ardleigh Swift, Co-Founder & VP Business Development
XOMA
Oscar Cuzzani, VP, Clinical Science
Tom Klein, VP & Chief Commercial Officer
Brion Raymond, Sr. Director, Marketing
Paul Rubin, Chief Medical Officer
John Varian, CEO
Ziemer Ophthalmic Systems AG
Sandro Palumbo, VP Marketing
Independent
Keith Barton, MD
Scott Beardsley
Andre Curi
William De La Pena, MD
Donald Fishbein, Healthcare Executive
Masayuki Kobayashi
Dr. Bruce M. Lennox, Physician
Julie Lyons
Marion Munk
Michael Nissen, MD, Physician
Andrew Schachat
Susan Schneider
Arunan Sivalingam, MD
Todd Smith
Document
Category
Business and Leadership
Views
1 175
File Size
453 KB
Tags
1/--pages
Report inappropriate content